These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 26125902

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B.
    Li L, Ma HQ.
    Mol Med Rep; 2015 Aug; 12(2):3156-62. PubMed ID: 25955794
    [Abstract] [Full Text] [Related]

  • 4. microRNA-188 is downregulated in oral squamous cell carcinoma and inhibits proliferation and invasion by targeting SIX1.
    Wang L, Liu H.
    Tumour Biol; 2016 Mar; 37(3):4105-13. PubMed ID: 26490981
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. miR-23a-3p suppresses cell proliferation in oral squamous cell carcinomas by targeting FGF2 and correlates with a better prognosis: miR-23a-3p inhibits OSCC growth by targeting FGF2.
    Chen F, Qi S, Zhang X, Wu J, Yang X, Wang R.
    Pathol Res Pract; 2019 Apr; 215(4):660-667. PubMed ID: 30606659
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
    Baba O, Hasegawa S, Nagai H, Uchida F, Yamatoji M, Kanno NI, Yamagata K, Sakai S, Yanagawa T, Bukawa H.
    J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
    [Abstract] [Full Text] [Related]

  • 11. MiR-92a regulates oral squamous cell carcinoma (OSCC) cell growth by targeting FOXP1 expression.
    Guo J, Wen N, Yang S, Guan X, Cang S.
    Biomed Pharmacother; 2018 Aug; 104():77-86. PubMed ID: 29772443
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tumor expression of miR-448 is a prognostic marker in oral squamous cell carcinoma.
    Wei H, Yu K, Liu Y, Li L, Wang G.
    BMC Cancer; 2020 Aug 12; 20(1):756. PubMed ID: 32787801
    [Abstract] [Full Text] [Related]

  • 18. MiR-139-5p inhibits the tumorigenesis and progression of oral squamous carcinoma cells by targeting HOXA9.
    Wang K, Jin J, Ma T, Zhai H.
    J Cell Mol Med; 2017 Dec 12; 21(12):3730-3740. PubMed ID: 28780773
    [Abstract] [Full Text] [Related]

  • 19. Downregulation of miR-377 Promotes Oral Squamous Cell Carcinoma Growth and Migration by Targeting HDAC9.
    Rastogi B, Kumar A, Raut SK, Panda NK, Rattan V, Joshi N, Khullar M.
    Cancer Invest; 2017 Mar 16; 35(3):152-162. PubMed ID: 28267394
    [Abstract] [Full Text] [Related]

  • 20. Suppressive effect of microRNA-126 on oral squamous cell carcinoma in vitro.
    Yang X, Wu H, Ling T.
    Mol Med Rep; 2014 Jul 16; 10(1):125-30. PubMed ID: 24789258
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.